IMNN Stock Analysis: Buy, Sell, or Hold?
IMNN - Imunon, Inc. Common Stock
$3.22
0.23 (7.69%)
▲
5d:
+18.82%
30d:
-6.94%
90d:
-15.49%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 31, 2026
0d
Get Alerted When IMNN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IMNN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: IMNN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: IMNN is currently trading at $3.22, which is considered slightly high relative to its 30-day fair value range of $2.89 to $3.25.
Technical Outlook: Technically, IMNN is in a strong downtrend. The price is approaching resistance at $3.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.7% recently.
Market Sentiment: IMNN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.50 (+567.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMNN is in a strong downtrend. The price is approaching resistance at $3.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.7% recently.
Market Sentiment: IMNN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.50 (+567.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.89 -
$3.25
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+7.7%)
- BULLISH: Trading 567.7% below Wall St target ($21.50)
Fair Price Analysis
30-Day Fair Range
$2.89 -
$3.25
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.52
Resistance Level
$3.08
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.02
Wall Street Target
$21.50
(+567.7%)
Share & Embed Analysis
Last updated: April 03, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$43 | 65 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
